Targeted Abdominal CT in Conjunction With Lung Cancer Screening
NCT ID: NCT07171190
Last Updated: 2025-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
6272 participants
INTERVENTIONAL
2025-11-11
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This group also has a high risk of developing abdominal cancers, such as kidney cancer. A recent study explored whether it would be feasible to extend the lung scan to include the abdomen. Results showed most participants supported this addition, and the number of serious findings was similar to those detected in UK breast or bowel cancer screening programmes.
However, the abdominal scan was only offered on the day of the lung scan, giving little time for people to consider their decision. The process also added too much time to be practical for widespread implementation.
This new study will:
* Test whether mentioning the possible abdominal scan in the initial LCS invitation affects participation in LCS assessments.
* Test new processes to assess if the abdominal scan can be added to the lung scan with minimal extra time.
* Check if participants can be split between the lung scan only group and lung and abdominal scan group using an approach called 'cluster randomisation'. This will be important in case a bigger trial is needed.
* See whether the additional processes are acceptable
People aged 55-70 who are invited to the lung cancer screening will be eligible to take part in this study. Only those who are found to be at a high risk of lung cancer after their assessment, and therefore offered a lung scan, will be offered the abdominal scan, provided they have not had an abdominal scan in the previous 12 months or one booked in the next 3 months.
This study will take place in two existing lung cancer screening locations in Yorkshire.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Invitation control arm
Invited to NHS Lung Cancer Screening to assess lung cancer risk via letter or text message, following the normal process
Lung Cancer Screening Invitation Intervention
Participants are invited to the NHS Lung Cancer Screening to assess lung cancer risk via letter or text message
Invitation intervention arm
Will have additional text included in the standard Lung Cancer Screening letter or text explaining that, if eligible, they may also be offered a scan of their abdomen at the same time as their lungs.
Lung Cancer Screening Invitation Intervention
Participants are invited to the NHS Lung Cancer Screening to assess lung cancer risk via letter or text message
Scan control arm
For the scan control batches, those who are 'high risk' following the LCS assessment will have an appointment booked for LCS in the normal way by the LCS assessor.
Abdominal scan intervention
Receiving an abdominal CT scan at the same time as the lung scan.
Scan intervention arm
Those who are 'high risk' following the LCS assessment will be invited to have an abdominal CT scan at the same time as their lung scan.
Abdominal scan intervention
Receiving an abdominal CT scan at the same time as the lung scan.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lung Cancer Screening Invitation Intervention
Participants are invited to the NHS Lung Cancer Screening to assess lung cancer risk via letter or text message
Abdominal scan intervention
Receiving an abdominal CT scan at the same time as the lung scan.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be registered with a GP in England.
* Be aged 55-70 years 364 days old at the date of invitation.
* Have been individually randomised to the invitation intervention arm
* Have booked in for a LCS assessment
* Have been randomised to the scan intervention cluster
* Be invited to attend for a LDCT Thorax based upon scores on either PLCOM2012 or Liverpool Lung Project (LLP) risk prediction models (PLCOM2012 risk of ≥1.51% over six years or LLPver2 five-year risk of ≥2.5%)14 during the LCS assessment.
* Have attended the lung scan appointment
* Have given electronic or written informed consent to participate
Exclusion Criteria
2. Eligibility criteria for the cluster level randomisation to scan intervention or scan control
* Participant does not have capacity to give consent (standard criteria for assessing capacity apply).
* Weight or physical size exceeds restrictions for scanner (\>200kg).
* Participant unable to lie flat.
* Poor physical fitness such that treatment with curative intent would be contra-indicated.
• Had an abdominal CT in the previous 12 months or has one booked within the next 3 months.
* For HNY, this is checked before the LCS assessment. Therefore, participants will be excluded before the LCS assessment.
* For WYH, this is only checked after the LCS assessment. Therefore, anyone having had an abdominal CT in the previous 12 months or with one booked within the next 3 months will be excluded at this point (see 8.6).
3. Eligibility criteria for the process evaluation Health care professionals: Healthcare professionals involved in the delivery of LCS in any of the study areas who agree to take part.
Participants: People individually randomised to the invitation intervention arm who attend the LCS assessment or the scanning unit within the study period and who agree to be interviewed.
55 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hull University Teaching Hospitals NHS Trust
OTHER_GOV
University of Cambridge
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Grant Stewart
Professor Grant Stewart
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hull Teaching Hospitals Trust
Hull, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Oliver Byass
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G128732
Identifier Type: -
Identifier Source: org_study_id